FDA Brief

Warning letters Drugs

FDA warning letter to

Grimann S.A. de C.V.

Issued May 23, 2022Posted May 31, 2022Center for Drug Evaluation and Research | CDER

Failure to Comply with Drug Registration and Listing Requirements. We haven't summarized this letter yet. Read it on fda.gov.